Next Article in Journal
Association between PDCD1 Gene Polymorphisms and Risk of Systemic Lupus Erythematosus in Three Main Ethnic Groups of the Malaysian Population
Next Article in Special Issue
Roles of Sestrin2 and Ribosomal Protein S6 in Transient Global Ischemia-Induced Hippocampal Neuronal Injury
Previous Article in Journal
Clouded Issues for PHACTR1
Open AccessReview

Changing the Face of Kynurenines and Neurotoxicity: Therapeutic Considerations

MTA-SZTE Neuroscience Research Group, Semmelweis u. 6, Szeged H-6725, Hungary
Department of Physiology, Anatomy and Neuroscience, Faculty of Science and Informatics, University of Szeged, Közép fasor 52, Szeged H-6726, Hungary
Institute of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Szeged, Eötvös utca 6, Szeged H-6720, Hungary
Department of Neurology, Faculty of Medicine, Albert Szent-Györgyi Clinical Center University of Szeged, Semmelweis u. 6, Szeged H-6725, Hungary
Author to whom correspondence should be addressed.
Academic Editor: Katalin Prokai-Tatrai
Int. J. Mol. Sci. 2015, 16(5), 9772-9793;
Received: 20 January 2015 / Revised: 9 April 2015 / Accepted: 13 April 2015 / Published: 29 April 2015
(This article belongs to the Special Issue Neuroprotective Strategies 2015)
Kynurenines are the products of tryptophan metabolism. Among them, kynurenine and kynurenic acid are generally thought to have neuroprotective properties, while 3-hydroxykynurenine, 3-hydroxyanthranilic acid and quinolinic acid are considered neurotoxic. They participate in immunoregulation and inflammation and possess pro- or anti-excitotoxic properties, and their involvement in oxidative stress has also been suggested. Consequently, it is not surprising that kynurenines have been closely related to neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis and multiple sclerosis. More information about the less-known metabolites, picolinic and cinnabarinic acid, evaluation of new receptorial targets, such as aryl-hydrocarbon receptors, and intensive research on the field of the immunomodulatory function of kynurenines delineated the high importance of this pathway in general homeostasis. Emerging knowledge about the kynurenine pathway provides new target points for the development of therapeutical solutions against neurodegenerative diseases. View Full-Text
Keywords: kynurenines; neurotoxicity; neurodegeneration kynurenines; neurotoxicity; neurodegeneration
Show Figures

Figure 1

MDPI and ACS Style

Bohár, Z.; Toldi, J.; Fülöp, F.; Vécsei, L. Changing the Face of Kynurenines and Neurotoxicity: Therapeutic Considerations. Int. J. Mol. Sci. 2015, 16, 9772-9793.

AMA Style

Bohár Z, Toldi J, Fülöp F, Vécsei L. Changing the Face of Kynurenines and Neurotoxicity: Therapeutic Considerations. International Journal of Molecular Sciences. 2015; 16(5):9772-9793.

Chicago/Turabian Style

Bohár, Zsuzsanna; Toldi, József; Fülöp, Ferenc; Vécsei, László. 2015. "Changing the Face of Kynurenines and Neurotoxicity: Therapeutic Considerations" Int. J. Mol. Sci. 16, no. 5: 9772-9793.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Search more from Scilit
Back to TopTop